PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Health Science Campus, Mail Stop #1007, 3000 Arlington Avenue, Toledo, OH, 43614-2598, USA.\', \'Department of Medical Microbiology and Immunology, University of Toledo, Toledo, OH, USA.\', \'Division of Biomedical Informatics, Cincinnati Children\'s Hospital Medical Center, Cincinnati, OH, USA.\', \'Department of Biomedical Informatics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\', \'Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\', \'Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\', \'Department of Electrical Engineering and Computing Systems, University of Cincinnati College of Medicine, Cincinnati, OH, USA.\', \'Department of Informatics, Nicolaus Copernicus University, Torun, Poland.\', \'Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Health Science Campus, Mail Stop #1007, 3000 Arlington Avenue, Toledo, OH, 43614-2598, USA. Robert.mccullumsmith@utoledo.edu.\', \'Neurosciences Institute, Promedica, Toledo, OH, USA. Robert.mccullumsmith@utoledo.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-84044-9
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33627767
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all